Atlas Trials

FGFR2 Gene Mutation

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch FGFR2 Gene Mutation

RecordFirmDate
Study to Evaluate the Efficacy and Safety of TT-00420 (Tinengotinib) in Cholangiocarcinoma (NCT04919642)TransThera Sciences (Nanjing), Inc.2021-12-07
Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib (NCT05052372)xCures2021-11-21
REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid Tumors (NCT04526106)Elevar Therapeutics2020-09-02
Pemigatinib for the Treatment of Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations (NCT04096417)Academic and Community Cancer Research United2020-08-31
Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations (NCT03773302)QED Therapeutics, a BridgeBio company2019-12-27
BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck Cancer (NCT02706691)University of Chicago2018-06-01
Lung-MAP: AZD4547 as Second-Line Therapy in Treating FGFR Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer (NCT02965378)SWOG Cancer Research Network2014-10-01
A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma (NCT02150967)QED Therapeutics, a BridgeBio company2014-07-23

Track FGFR2 Gene Mutation automatically

Every clearance here is in the API, with alerts when new ones post.